| 1. | | Recruiting | 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer |
| 2. | | Recruiting | Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
Conditions: stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia; ... |
| 3. | | Recruiting | Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
Conditions: Drug Toxicity; primary systemic amyloidosis |
| 4. | | Recruiting | Anastrozole and Gefitinib Compared With Fulvestrant and Gefitinib in Treating Postmenopausal Women With Recurrent or Metastatic Breast Cancer
Conditions: recurrent breast cancer; stage IV breast cancer |
| 5. | | Recruiting | Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; Infection |
| 6. | | Recruiting | Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 7. | | Recruiting | BAY 43-9006 in Treating Patients With Refractory Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ... |
| 8. | | Recruiting | Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation
Condition: refractory plasma cell neoplasm |
| 9. | | Recruiting | Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck
Conditions: lip and oral cavity cancer; Salivary Gland Cancer |
| 10. | | Recruiting | Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
Condition: stage III multiple myeloma |
| 11. | | Recruiting | Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia |
| 12. | | Recruiting | Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 13. | | Recruiting | Carboplatin Combined with Paclitaxel in Treating Patients With Advanced Thymoma
Conditions: invasive thymoma and thymic carcinoma; recurrent thymoma and thymic carcinoma |
| 14. | | Recruiting | Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Treating Patients With Stage III Non-small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung; Adenosquamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; large cell lung cancer; Non-small cell lung cancer; ... |
| 15. | | Not yet recruiting | Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
Conditions: Cachexia; Cancer; Pain |
| 16. | | Not yet recruiting | Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ... |
| 17. | | Recruiting | Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ... |
| 18. | | Recruiting | Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ... |
| 19. | | Recruiting | Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
Conditions: stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 20. | | Recruiting | Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Conditions: refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma |
| 21. | | Recruiting | Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Conditions: Esophageal Cancer; Gastric Cancer |
| 22. | | Recruiting | Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer |
| 23. | | Recruiting | Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
Conditions: stage III melanoma; Recurrent Melanoma |
| 24. | | Recruiting | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Conditions: stage II anal cancer; stage III anal cancer; squamous cell carcinoma of the anus; cloacogenic carcinoma of the anus; basaloid carcinoma of the anus |
| 25. | | Recruiting | Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Condition: extensive stage small cell lung cancer |
| 26. | | Recruiting | Combination Chemotherapy and Radiation Therapy With or Without Surgery In Treating Patients With Stage II or Stage III Bladder Cancer
Conditions: stage II bladder cancer; stage III bladder cancer |
| 27. | | Recruiting | Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma or High-Risk Stage I Non-Hodgkin's Lymphoma
Conditions: AIDS-related diffuse large cell lymphoma; AIDS-related immunoblastic large cell lymphoma; AIDS-related peripheral/systemic lymphoma; ... |
| 28. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer
Conditions: Adult Medulloblastoma; adult anaplastic ependymoma; adult ependymoma; adult supratentorial primitive neuroectodermal tumor (PNET) |
| 29. | | Recruiting | Combination Chemotherapy With or Without Monoclonal Antibody Therapy Followed by Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia |
| 30. | | Recruiting | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Condition: adult Hodgkin's lymphoma |
| 31. | | Recruiting | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
| 32. | | Recruiting | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 33. | | Recruiting | Comparison of Adjuvant Chemotherapy Regimens in Treating Patients With Stage II or Stage III Rectal Cancer Who Are Receiving Radiation Therapy and Fluorouracil Before or After Surgery
Conditions: adenocarcinoma of the rectum; stage II rectal cancer; stage III rectal cancer |
| 34. | | Recruiting | Comparison of Adjuvant Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients With Resected Stage III Colon Cancer
Conditions: stage III colon cancer; adenocarcinoma of the colon |
| 35. | | Recruiting | Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
| 36. | | Recruiting | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: extensive stage small cell lung cancer |
| 37. | | Recruiting | Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
Conditions: stage III endometrial cancer; endometrial adenocarcinoma; endometrial adenosquamous cell carcinoma; endometrial adenoacanthoma; ... |
| 38. | | Not yet recruiting | Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma
Condition: angioimmunoblastic T-cell lymphoma |
| 39. | | Recruiting | Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Conditions: adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma |
| 40. | | Recruiting | Daunorubicin and Cytarabine With or Without Zosuquidar Trihydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; Myelodysplastic Syndromes; secondary acute myeloid leukemia |
| 41. | | Recruiting | Diagnostic Study of Patients With Stage I Testicular Cancer
Condition: Testicular Cancer |
| 42. | | Recruiting | Docetaxel With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer |
| 43. | | Recruiting | Doxorubicin and Bortezomib in Treating Patients With Liver Cancer
Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer; ... |
| 44. | | Recruiting | Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma (Kidney Cancer)
Conditions: stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 45. | | Recruiting | Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
Conditions: recurrent prostate cancer; Anemia; Fatigue |
| 46. | | Not yet recruiting | Erlotinib in Treating Patients With Early-Stage Non-Small Cell Lung Cancer
Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer |
| 47. | | Not yet recruiting | Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 48. | | Recruiting | Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer
Conditions: stage I esophageal cancer; stage II esophageal cancer; stage III esophageal cancer |
| 49. | | Recruiting | Exemestane Compared With Anastrozole, With or Without Celecoxib, in Treating Postmenopausal Women After Surgery for Primary Breast Cancer
Conditions: stage IIIA breast cancer; stage I breast cancer; stage II breast cancer |
| 50. | | Recruiting | Gefitinib in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed
Condition: Non-small cell lung cancer |
